ArticleNeurogastroenterology and motility2015

Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1.

A Shiotani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.